Gut bacteria may reveal arthritis risk in Crohn's patients

NCT ID NCT03983473

Recruiting now Knowledge-focused Sponsor: Central Hospital, Nancy, France Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares the gut microbiome—bacteria, fungi, and viruses—in people with Crohn's disease, with or without arthritis, and healthy controls. Researchers aim to find microbial biomarkers linked to arthritis in Crohn's patients. No treatment is given; it is purely observational.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could help identify gut microbiome patterns linked to arthritis in Crohn's patients, potentially guiding future diagnostic tools.
What could go wrong: This is an observational study, not a treatment trial. It may not find clear biomarkers, and results may not lead to immediate clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease Spondylarthritis spondyloarthropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CROHN DISEASE SPONDYLOARTHRITIS

Contacts and locations

Locations

Central Hospital
RECRUITING

Nancy, Lorraine, 54500, France
Saint Antoine Hospital
RECRUITING

Paris, 75012, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.